Chordoma is a rare type of cancer that develops in the bones of the skull base and spine. It arises from remnants of the notochord, a structure present during early fetal development. Chordomas typically grow slowly and can cause symptoms such as persistent pain, difficulty swallowing, and changes in vision or hearing, depending on their location. They are most commonly found in the sacrum, a triangular bone at the base of the spine, or in the bones of the skull.
Chordomas are considered to be low-grade malignant tumors, meaning they have the potential to spread to nearby tissues but rarely metastasize to distant sites. They are often challenging to treat due to their location and tendency to recur after treatment. Treatment options for chordoma may include surgery, radiation therapy, and targeted drug therapy. A multidisciplinary approach involving specialists from various fields is crucial in managing chordoma cases.
While chordoma is a serious condition, ongoing research and advancements in treatment options offer hope for improved outcomes and quality of life for individuals affected by this rare cancer.